The Analysis Study of Prevalence, Management, and Outcome of Steven Johnson Syndrome and Toxic Epidermal Necrolysis in Pregnant Patients : A Comprehensive Systematic Review
Keywords:
Pregnant, toxic epidermal necrolysis (TEN), Steven Johnson syndrome (SJS)Abstract
Background: Toxic epidermal necrolysis (TEN) and Stevens-Johnson syndrome (SJS) are uncommon, potentially fatal cutaneous drug reactions that affect the skin and mucous membranes and are thought to be different manifestations of the same illness. The aim: The purpose of this study is to demonstrate the incidence, treatment, and prognosis of toxic epidermal necrolysis and Steven Johnson syndrome in pregnant individuals. Methods: The Preferred Reporting Items for Systematic Review and Meta-Analysis (PRISMA) 2020 was utilized to demonstrate that this study complied with all applicable standards. With this search strategy, articles published between 2014 and 2024 were taken into consideration. This was accomplished by utilizing a number of distinct online reference sites, including Sciencedirect, Pubmed, and SagePub. It was determined that reviews, previously published works, and partially completed works would not be included. Result: Following a thorough three-level screening process, eight publications were determined to be closely connected to our ongoing systematic examination. Following that, an extensive examination of the entire text was carried out, and these articles were subjected to further inspection. Conclusion: SJS/TEN during pregnancy seems to be benign and is linked to good outcomes for both the mother and the fetus, with the exception of a higher risk of preterm birth. The extreme form of the illness, known as TEN, has been linked to worse outcomes for fetuses. Pregnant HIV-positive women do not have an increase in SJS/TEN-associated mortality. It doesn't appear that maternal SJS/TEN frequently shows up in the fetus.
References
Spillers NJ, Luther PM, Talbot NC, Ly GH, Downs EM, Lavespere G, et al. Association of Acetaminophen With Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis: Pharmacologic Considerations and Treatment Options. Cureus. 2023;15(6):5–11.
Schneider JA, Cohen PR. Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis: A Concise Review with a Comprehensive Summary of Therapeutic Interventions Emphasizing Supportive Measures. Adv Ther [Internet]. 2017 Jun 24;34(6):1235–44. Available from: http://link.springer.com/10.1007/s12325-017-0530-y
Chateau A V., Dlova NC, Dawood H, Aldous C. Outcomes of Stevens–Johnson syndrome and toxic epidermal necrolysis in HIV-infected patients when using systemic steroids and/or intravenous immunoglobulins in Pietermaritzburg, South Africa. South Afr J HIV Med. 2019;20(1):1–8.
Shrestha O, Pant P, Devkota N, Gurung D, Shrestha DB. Carbamazepine induced toxic epidermal necrolysis and Stevens-Johnson syndrome overlapping during pregnancy in a South-East Asian patient: A case report. Ann Med Surg [Internet]. 2021;68(July):102616. Available from: https://doi.org/10.1016/j.amsu.2021.102616
White KD, Abe R, Ardern-Jones M, Beachkofsky T, Bouchard C, Carleton B, et al. SJS/TEN 2017: Building Multidisciplinary Networks to Drive Science and Translation. J Allergy Clin Immunol Pract. 2018;6(1):38–69.
Wang L, Varghese S, Bassir F, Lo YC, Ortega CA, Shah S, et al. Stevens-Johnson syndrome and toxic epidermal necrolysis: A systematic review of PubMed/MEDLINE case reports from 1980 to 2020. Front Med. 2022;9(August):1–18.
Petukhova TA, Maverakis E, Ho B, Sharon VR. Urogynecologic complications in Stevens-Johnson syndrome and toxic epidermal necrolysis: Presentation of a case and recommendations for management. JAAD Case Reports [Internet]. 2016 May;2(3):202–5. Available from: https://linkinghub.elsevier.com/retrieve/pii/S2352512616300078
SHAKOEI S, DANESHPAZHOOH M, NASIMI M, HAMZELOU S. Toxic epidermal necrolysis in pregnancy due to ondansetron with a favorable outcome: A case report and review of the literature. J Clin Aesthet Dermatol. 2021;14(5):46–9.
Velter C, Hotz C, Ingen-Housz-Oro S, Wolkenstein P, Fardet L. Stevens-johnson syndrome during pregnancy: Case report of a newborn treated with the culprit drug. JAMA Dermatology. 2018;154(2):224–5.
El Daief SG, Das S, Ekekwe G, Nwosu EC. A successful pregnancy outcome after Stevens-Johnson Syndrome. J Obstet Gynaecol (Lahore). 2014;34(5):445–6.
Knight L, Todd G, Muloiwa R, Matjila M, Lehloenya RJ. Stevens Johnson syndrome and toxic epidermal necrolysis: Maternal and foetal outcomes in twenty-two consecutive pregnant HIV infected women. PLoS One. 2015;10(8):1–11.
Wasuwanich P, Egerman RS, Wen TS, Motaparthi K. A nationwide study of Stevens–Johnson syndrome and toxic epidermal necrolysis in hospitalized pregnant women in the United States, 2009–2020. JAAD Int [Internet]. 2024;16:175–82. Available from: https://doi.org/10.1016/j.jdin.2024.04.002
Yang MS, Lee JY, Kim J, Kim GW, Kim BK, Kim JY, et al. Incidence of stevens-johnson syndrome and toxic epidermal necrolysis: A nationwide population-based study using national health insurance database in Korea. PLoS One. 2016;11(11):1–12.
Sharma AN, Hedayati B, Mesinkovska NA, Worswick S. Stevens-Johnson syndrome and toxic epidermal necrolysis in pregnant patients: A systematic review. Int J Women’s Dermatology [Internet]. 2020;6(4):239–47. Available from: https://doi.org/10.1016/j.ijwd.2020.04.002
Senda A, Fushimi K. Effectiveness of early treatment with plasma exchange in patients with Stevens–Johnson syndrome and toxic epidermal necrolysis. Sci Rep [Internet]. 2024;14(1):1–5. Available from: https://doi.org/10.1038/s41598-024-53653-5
Gronich N, Maman D, Stein N, Saliba W. Culprit Medications and Risk Factors Associated with Stevens–Johnson Syndrome and Toxic Epidermal Necrolysis: Population-Based Nested Case–Control Study. Am J Clin Dermatol [Internet]. 2022;23(2):257–66. Available from: https://doi.org/10.1007/s40257-021-00661-0
Carrasquillo OY, Santiago-Vazquez M, Cardona R, Cruz-Manzano M, Figueroa LD. Stevens-Johnson syndrome and toxic epidermal necrolysis: a retrospective descriptive study. Int J Dermatol. 2019;58(11):1293–9.
Wasuwanich P, So JM, Chakrala TS, Chen J, Motaparthi K. Epidemiology of Stevens-Johnson syndrome and toxic epidermal necrolysis in the United States and factors predictive of outcome. JAAD Int [Internet]. 2023;13:17–25. Available from: https://doi.org/10.1016/j.jdin.2023.06.014
Lamichhane R, Pandey MR, Dhungana A, Lamsal A. Terbinafine-induced Toxic Epidermal Necrolysis in Pregnancy: A Case Report. J Nepal Med Assoc. 2023;61(260):379–82.
Kumar R, Das A, Das S. Management of Stevens-Johnson Syndrome-Toxic Epidermal Necrolysis: Looking Beyond Guidelines! Indian J Dermatol [Internet]. 2018;63(2):117–24. Available from: http://www.ncbi.nlm.nih.gov/pubmed/29692452
Noe MH, Rosenbach M, Hubbard RA, Mostaghimi A, Cardones AR, Chen JK, et al. Development and Validation of a Risk Prediction Model for In-Hospital Mortality Among Patients With Stevens-Johnson Syndrome/Toxic Epidermal Necrolysis-ABCD-10. JAMA dermatology [Internet]. 2019 Apr 1;155(4):448–54. Available from: http://www.ncbi.nlm.nih.gov/pubmed/30840032
Hsu DY, Brieva J, Silverberg NB, Silverberg JI. Morbidity and Mortality of Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis in United States Adults. J Invest Dermatol [Internet]. 2016;136(7):1387–97. Available from: http://dx.doi.org/10.1016/j.jid.2016.03.023
Frey N, Jossi J, Bodmer M, Bircher A, Jick SS, Meier CR, et al. The Epidemiology of Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis in the UK. J Invest Dermatol [Internet]. 2017;137(6):1240–7. Available from: http://dx.doi.org/10.1016/j.jid.2017.01.031
Fakoya AOJ, Omenyi P, Anthony P, Anthony F, Etti P, Otohinoyi DA, et al. Stevens - Johnson syndrome and toxic epidermal necrolysis; extensive review of reports of drug-induced etiologies, and possible therapeutic modalities. Open Access Maced J Med Sci. 2018;6(4):730–8.
Calley BJ, Saleh J, Young K, Wanat KA. Stevens-Johnson syndrome in a pregnant woman who received the influenza vaccine. JAAD Case Reports [Internet]. 2022;23:35–7. Available from: https://doi.org/10.1016/j.jdcr.2022.02.002
Downloads
Published
Issue
Section
License
Copyright (c) 2025 Deanurva Calista Prima, Wahyu Rhomadon (Author)
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
Authors publishing here keep copyright but grant the journal first publication rights, under a Creative Commons Attribution-NonCommercial 4.0 License. They can distribute their work non-exclusively elsewhere with an acknowledgment of its first publication in this journal. Posting the work online before and during submission for earlier and greater citation is encouraged, reflecting Open Access benefits.
